Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small nuclear ribonucleoprotein polypeptide C pseudogene 19 (SNRPCP19) is classified as a pseudogene in the human genome[5]. It does not code for a functional protein, but is a non-functional genomic sequence that resembles the protein-coding gene for small nuclear ribonucleoprotein polypeptide C—a component of small nuclear ribonucleoprotein complexes (snRNPs) involved in splicing of precursor mRNA. While a few pseudogenes may have regulatory roles as non-coding RNAs, there is no evidence that SNRPCP19 is functional or therapeutic target relevant[5][2]. No disease associations, interacting drugs, or biomarker relevance are reported. Key notes: - The listing is a pseudogene, not a functional gene or protein. - It is not a receptor, enzyme, transporter, or other common therapeutic target class. - No disease links, functional roles, targeting drugs, or safety concerns are reported in the available literature. - The entry is valid as a pseudogene, but it is not a relevant biological or drug target in any recognized context[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nuclear ribonucleoprotein polypeptide C pseudogene 19 (SNRPCP19).